CN1717232A - L－肉碱用于治疗心血管疾病的用途 - Google Patents

L－肉碱用于治疗心血管疾病的用途 Download PDF

Info

Publication number
CN1717232A
CN1717232A CNA2004800015143A CN200480001514A CN1717232A CN 1717232 A CN1717232 A CN 1717232A CN A2004800015143 A CNA2004800015143 A CN A2004800015143A CN 200480001514 A CN200480001514 A CN 200480001514A CN 1717232 A CN1717232 A CN 1717232A
Authority
CN
China
Prior art keywords
carnitine
purposes according
acid
myocardial infarction
acute myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800015143A
Other languages
English (en)
Chinese (zh)
Inventor
A·卡沃勒驰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN1717232A publication Critical patent/CN1717232A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2004800015143A 2003-04-17 2004-03-03 L－肉碱用于治疗心血管疾病的用途 Pending CN1717232A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.
ITRM2003A000178 2003-04-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2008101490996A Division CN101467992A (zh) 2003-04-17 2004-03-03 L-肉碱用于治疗心血管疾病的用途

Publications (1)

Publication Number Publication Date
CN1717232A true CN1717232A (zh) 2006-01-04

Family

ID=29765768

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2004800015143A Pending CN1717232A (zh) 2003-04-17 2004-03-03 L－肉碱用于治疗心血管疾病的用途
CNA2008101490996A Pending CN101467992A (zh) 2003-04-17 2004-03-03 L-肉碱用于治疗心血管疾病的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2008101490996A Pending CN101467992A (zh) 2003-04-17 2004-03-03 L-肉碱用于治疗心血管疾病的用途

Country Status (11)

Country Link
US (1) US20060052450A1 (https=)
EP (1) EP1613301A1 (https=)
JP (1) JP2006523685A (https=)
KR (1) KR20050121196A (https=)
CN (2) CN1717232A (https=)
AU (2) AU2004229256A1 (https=)
BR (1) BRPI0406552A (https=)
CA (1) CA2508636A1 (https=)
IT (1) ITRM20030178A1 (https=)
MX (1) MXPA05007612A (https=)
WO (1) WO2004091602A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073705A (zh) * 2020-08-14 2022-02-22 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040346A1 (it) 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20070260674A1 (en) * 2006-05-02 2007-11-08 Research In Motion Limited Push framework for delivery of dynamic mobile content
US20110105400A1 (en) * 2008-03-26 2011-05-05 Orthologic Corp. Methods for treating acute myocardial infarction
EP2353596A1 (en) 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
SG194679A1 (en) 2011-05-03 2013-12-30 Sigma Tau Ind Farmaceuti Composition useful for the treatment of lipid metabolism disorders
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS531812B2 (https=) * 1972-12-07 1978-01-23
AU1295700A (en) * 1998-11-26 2000-06-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073705A (zh) * 2020-08-14 2022-02-22 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用
CN114073705B (zh) * 2020-08-14 2026-03-10 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用

Also Published As

Publication number Publication date
WO2004091602A1 (en) 2004-10-28
ITRM20030178A1 (it) 2004-10-18
CN101467992A (zh) 2009-07-01
AU2004229256A1 (en) 2004-10-28
US20060052450A1 (en) 2006-03-09
KR20050121196A (ko) 2005-12-26
CA2508636A1 (en) 2004-10-28
ITRM20030178A0 (it) 2003-04-17
MXPA05007612A (es) 2005-09-30
JP2006523685A (ja) 2006-10-19
BRPI0406552A (pt) 2005-12-20
EP1613301A1 (en) 2006-01-11
AU2010202396A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
AU2010202396A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
JP3616116B2 (ja) 心臓血管障害の処置のためのａｃｅ阻害剤を配合するｌ−カルニチンまたはアシル−ｌ−カルニチンを含む医薬組成物
JP4370169B2 (ja) 勃起障害の治療のためのアルカノイルｌ−カルニチンの使用
JP2006523685A5 (https=)
CN102349923B (zh) L-肉碱和葡萄糖治疗心血管疾病的应用
HK1085929A (en) Use of l-carnitine for the treatment of cardiovascular diseases
HK1132174A (en) Use of l-carnitine for the treatment of cardiovascular diseases
HK1113542B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
HK1166003B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
US20090042983A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
EP1937245A1 (en) Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
CN1433302A (zh) 氢化可的松拮抗剂在治疗心力衰竭中的应用
JP2008517872A5 (https=)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1085929

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060104

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1085929

Country of ref document: HK